Vincerx Pharma Inc [VINC] stock prices are down -7.95% to $0.54 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The VINC shares have lost -5.57% over the last week, with a monthly amount drifted -34.57%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Vincerx Pharma Inc [NASDAQ: VINC] stock has seen the most recent analyst activity on January 14, 2022, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $25. Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on December 23, 2021, and set its price target to $25. On November 01, 2021, SVB Leerink initiated with a Outperform rating and assigned a price target of $24 on the stock. Laidlaw started tracking the stock assigning a Buy rating and suggested a price target of $30 on September 13, 2021. B. Riley Securities initiated its recommendation with a Buy and recommended $26 as its price target on August 25, 2021.
The stock price of Vincerx Pharma Inc [VINC] has been fluctuating between $0.48 and $113.40 over the past year. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Vincerx Pharma Inc [NASDAQ: VINC] shares were valued at $0.54 at the most recent close of the market. An investor can expect a potential return of 455.56% based on the average VINC price forecast.
Analyzing the VINC fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -3.76, Equity is -4.51 and Total Capital is -11.55.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.5000 points at the first support level, and at 0.4600 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.5900, and for the 2nd resistance point, it is at 0.6400.
Ratios To Look Out For
It’s worth pointing out that Vincerx Pharma Inc [NASDAQ:VINC]’s Current Ratio is 1.21. In addition, the Quick Ratio stands at 1.21 and the Cash Ratio stands at 0.94.
